The P2Yreceptor agonist may be administered with therapeutic and adjuvant agents commonly used to treat edematous retinal disorders.
上述P 2y受体拮抗剂可以和通常用于治疗水肿性视网膜疾病的治疗剂和佐剂一起施用。
2
The several kinds of P2X and P2Yreceptor subtypes have been expressed in vascular endothelial cells and vascular smooth muscle cells.
血管内皮细胞及平滑肌细胞有多种P 2x和P 2y受体亚型表达。
3
The pharmaceutical composition useful in this invention comprises a P2Yreceptor agonist with enhanced resistance to extracellular hydrolysis, such as dinucleoside polyphosphate compounds.